Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk.

Spratt DE, Schaeffer EM.

Eur Urol. 2018 Jun 12. pii: S0302-2838(18)30426-3. doi: 10.1016/j.eururo.2018.06.001. [Epub ahead of print] No abstract available.

PMID:
29907357
2.

The Influence of decision aids on prostate cancer screening preferences: A randomized survey study.

Weiner AB, Tsai KP, Keeter MK, Victorson DE, Schaeffer EM, Catalona WJ, Kundu SD.

J Urol. 2018 May 28. pii: S0022-5347(18)43270-3. doi: 10.1016/j.juro.2018.05.093. [Epub ahead of print]

PMID:
29852180
3.

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.

Kaur HB, Guedes LB, Lu J, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tosoian JJ, Tomlins SA, Schaeffer EM, Joshu CE, Sfanos KS, Lotan TL.

Mod Pathol. 2018 May 30. doi: 10.1038/s41379-018-0083-x. [Epub ahead of print]

PMID:
29849114
4.

Re: Safety and Efficacy of Intravesical Alum for Intractable Hemorrhagic Cystitis: A Contemporary Evaluation.

Schaeffer EM.

J Urol. 2018 Jun;199(6):1377. doi: 10.1016/j.juro.2018.03.024. Epub 2018 Mar 16. No abstract available.

PMID:
29783557
5.

Re: Pre- and Postoperative Predictors of Infection-Related Complications in Patients Undergoing Percutaneous Nephrolithotomy.

Schaeffer EM.

J Urol. 2018 Jun;199(6):1376-1377. doi: 10.1016/j.juro.2018.03.023. Epub 2018 Mar 16. No abstract available.

PMID:
29783554
6.

Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.

Karnes RJ, Sharma V, Choeurng V, Ashab HA, Erho N, Alshalalfa M, Trock B, Ross A, Yousefi K, Tsai H, Zhao SG, Tosoian JJ, Haddad Z, Takhar M, Chang SL, Spratt DE, Abdollah F, Jenkins RB, Klein EA, Nguyen PL, Dicker AP, Den RB, Davicioni E, Feng FY, Lotan TL, Schaeffer EM.

Clin Cancer Res. 2018 May 14. doi: 10.1158/1078-0432.CCR-17-2745. [Epub ahead of print]

PMID:
29760221
7.

Re: Analysis of Factors' Association with Risk of Postoperative Urosepsis in Patients Undergoing Ureteroscopy for Treatment of Stone Disease.

Schaeffer EM.

J Urol. 2018 May;199(5):1093. doi: 10.1016/j.juro.2018.02.025. Epub 2018 Feb 17. No abstract available.

PMID:
29677866
8.

Re: Evaluation of Targeted Antimicrobial Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy: A Prospective Cohort Trial.

Schaeffer EM.

J Urol. 2018 May;199(5):1092-1093. doi: 10.1016/j.juro.2018.02.024. Epub 2018 Feb 17. No abstract available.

PMID:
29677863
9.

Re: Selective Depletion of Uropathogenic E. coli from the Gut by a FimH Antagonist.

Schaeffer EM.

J Urol. 2018 Apr;199(4):874-875. doi: 10.1016/j.juro.2018.01.017. Epub 2018 Jan 9. No abstract available.

PMID:
29642325
10.

Re: Symptomatic Treatment of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting: Randomised, Double Blind Trial.

Schaeffer EM.

J Urol. 2018 Apr;199(4):874-875. doi: 10.1016/j.juro.2018.01.018. Epub 2018 Jan 9. No abstract available.

PMID:
29642324
11.

Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer.

Benzon B, Glavaris SA, Simons BW, Hughes RM, Ghabili K, Mullane P, Miller R, Nugent K, Shinder B, Tosoian J, Fuchs EJ, Tran PT, Hurley PJ, Vuica-Ross M, Schaeffer EM, Drake CG, Ross AE.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):126-136. doi: 10.1038/s41391-018-0035-z. Epub 2018 Mar 20.

PMID:
29556048
12.

Re: Six Weeks of Fluoroquinolone Antibiotic Therapy for Patients with Elevated Serum Prostate-Specific Antigen is Not Clinically Beneficial: A Randomized Controlled Clinical Trial.

Schaeffer EM.

J Urol. 2017 May;197(5):1276. doi: 10.1016/j.juro.2017.02.058. Epub 2017 Feb 21. No abstract available.

PMID:
29539905
13.

Re: A Single Dose of Intraoperative Antibiotics is Sufficient to Prevent Urinary Tract Infection During Ureteroscopy.

Schaeffer EM.

J Urol. 2017 May;197(5):1276. doi: 10.1016/j.juro.2017.02.057. Epub 2017 Feb 21. No abstract available.

PMID:
29539904
14.

Re: Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Schaeffer EM.

J Urol. 2017 May;197(5):1275-1276. doi: 10.1016/j.juro.2017.02.056. Epub 2017 Feb 21. No abstract available.

PMID:
29539903
15.

Re: Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship.

Schaeffer EM.

J Urol. 2017 May;197(5):1275. doi: 10.1016/j.juro.2017.01.017. Epub 2017 Jan 10. No abstract available.

PMID:
29539902
16.

Re: Effects of Perioperative Supplementation with Pro-/Synbiotics on Clinical Outcomes in Surgical Patients: A Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials.

Schaeffer EM.

J Urol. 2017 May;197(5):1274-1275. doi: 10.1016/j.juro.2017.01.016. Epub 2017 Jan 10. No abstract available.

PMID:
29539901
17.

Re: Adaptation of Escherichia coli Traversing from the Faecal Environment to the Urinary Tract.

Schaeffer EM.

J Urol. 2017 May;197(5):1274-1275. doi: 10.1016/j.juro.2017.01.015. Epub 2017 Jan 10. No abstract available.

PMID:
29539900
18.

Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.

Mahal BA, Yang DD, Wang NQ, Alshalalfa M, Davicioni E, Choeurng V, Schaeffer EM, Ross AE, Spratt DE, Den RB, Martin NE, Mouw KW, Orio PF 3rd, Choueiri TK, Taplin ME, Trinh QD, Feng FY, Nguyen PL.

Eur Urol. 2018 Aug;74(2):146-154. doi: 10.1016/j.eururo.2018.01.043. Epub 2018 Feb 22.

PMID:
29478736
19.

Re: Bacterial Resistance in Urinary Tract Infections in Patients with Diabetes Matched with Patients without Diabetes.

Schaeffer EM.

J Urol. 2017 Aug;198(2):232. doi: 10.1016/j.juro.2017.05.005. Epub 2017 May 4. No abstract available.

PMID:
29370606
20.

Re: Efficacy of Tamsulosin, Oxybutynin, and Their Combination in the Control of Double-J Stent-Related Lower Urinary Tract Symptoms.

Schaeffer EM.

J Urol. 2018 Feb;199(2):326. doi: 10.1016/j.juro.2017.11.042. Epub 2017 Nov 9. No abstract available.

PMID:
29357534
21.

Gender Representation in Urologic Subspecialties.

Nettey OS, Fuchs JS, Kielb SJ, Schaeffer EM.

Urology. 2018 Apr;114:66-70. doi: 10.1016/j.urology.2017.12.034. Epub 2018 Jan 10.

PMID:
29331304
22.

Re: Incidence of Urinary Tract Infection among Siblings of Children with Vesicoureteral Reflux.

Schaeffer EM.

J Urol. 2018 Jan;199(1):13. doi: 10.1016/j.juro.2017.09.106. Epub 2017 Oct 9. No abstract available.

PMID:
29310156
23.

Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.

Bernstein AN, Shoag JE, Golan R, Halpern JA, Schaeffer EM, Hsu WC, Nguyen PL, Sedrakyan A, Chen RC, Eggener SE, Hu JC.

J Urol. 2018 Jun;199(6):1510-1517. doi: 10.1016/j.juro.2017.12.048. Epub 2017 Dec 26.

PMID:
29288121
24.

Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.

Ross AE, Hughes RM, Glavaris S, Ghabili K, He P, Anders NM, Harb R, Tosoian JJ, Marchionni L, Schaeffer EM, Partin AW, Allaf ME, Bivalacqua TJ, Chapman C, O'Neal T, DeMarzo AM, Hurley PJ, Rudek MA, Antonarakis ES.

Oncotarget. 2017 Oct 26;8(61):104182-104192. doi: 10.18632/oncotarget.22115. eCollection 2017 Nov 28.

25.

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.

Spratt DE, Dai DLY, Den RB, Troncoso P, Yousefi K, Ross AE, Schaeffer EM, Haddad Z, Davicioni E, Mehra R, Morgan TM, Rayford W, Abdollah F, Trabulsi E, Achim M, Tapia ELN, Guerrero M, Karnes RJ, Dicker AP, Hurwitz MA, Nguyen PL, Feng FFY, Freedland SJ, Davis JW.

Eur Urol. 2018 Jul;74(1):107-114. doi: 10.1016/j.eururo.2017.11.024. Epub 2017 Dec 10.

PMID:
29233664
26.

Active Surveillance for Prostate Cancer.

Matulewicz RS, Weiner AB, Schaeffer EM.

JAMA. 2017 Dec 5;318(21):2152. doi: 10.1001/jama.2017.17222. No abstract available.

PMID:
29209723
27.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL.

J Clin Oncol. 2018 Feb 20;36(6):581-590. doi: 10.1200/JCO.2017.74.2940. Epub 2017 Nov 29.

PMID:
29185869
28.

The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).

Weiner AB, Matulewicz RS, Tosoian JJ, Feinglass JM, Schaeffer EM.

Urol Oncol. 2018 Mar;36(3):91.e1-91.e6. doi: 10.1016/j.urolonc.2017.10.023. Epub 2017 Nov 15.

29.

Re: The Effectiveness of Prophylactic Antibiotics with Oral Levofloxacin against Post-Shock Wave Lithotripsy Infectious Complications: A Randomized Controlled Trial.

Schaeffer EM.

J Urol. 2017 Dec;198(6):1190. doi: 10.1016/j.juro.2017.09.061. Epub 2017 Sep 14. No abstract available.

PMID:
29144909
30.

Re: Prevalence of Sexual Dysfunction in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Meta-Analysis.

Schaeffer EM.

J Urol. 2017 Dec;198(6):1190. doi: 10.1016/j.juro.2017.09.062. Epub 2017 Sep 14. No abstract available.

PMID:
29144908
31.

Contemporary management of men with high-risk localized prostate cancer in the United States.

Weiner AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener SE.

Prostate Cancer Prostatic Dis. 2017 Dec;20(4):442. doi: 10.1038/pcan.2017.35.

PMID:
29125150
32.

Re: Etiology of Symptomatic Urethritis in Men and Association with Sexual Behaviors.

Schaeffer EM.

J Urol. 2017 Nov;198(5):962. doi: 10.1016/j.juro.2017.08.038. Epub 2017 Aug 9. No abstract available.

PMID:
29059739
33.

Re: Management of Bacteriuria in Veterans Affairs Hospitals.

Schaeffer EM.

J Urol. 2017 Nov;198(5):961-962. doi: 10.1016/j.juro.2017.08.016. Epub 2017 Aug 9. No abstract available.

PMID:
29059738
34.

Re: Development and Characterization of a Stable Adhesive Bond between a Poly(dimethylsiloxane) Catheter Material and a Bacterial Biofilm Resistant Acrylate Polymer Coating.

Schaeffer EM.

J Urol. 2017 Oct;198(4):726. doi: 10.1016/j.juro.2017.07.007. Epub 2017 Jul 7. No abstract available.

PMID:
28905757
35.
36.

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.

Labbé DP, Sweeney CJ, Brown M, Galbo P, Rosario S, Wadosky KM, Ku SY, Sjöström M, Alshalalfa M, Erho N, Davicioni E, Karnes RJ, Schaeffer EM, Jenkins RB, Den RB, Ross AE, Bowden M, Huang Y, Gray KP, Feng FY, Spratt DE, Goodrich DW, Eng KH, Ellis L.

Clin Cancer Res. 2017 Nov 15;23(22):7072-7083. doi: 10.1158/1078-0432.CCR-17-0413. Epub 2017 Sep 12.

PMID:
28899973
37.

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.

Alshalalfa M, Verhaegh GW, Gibb EA, Santiago-Jiménez M, Erho N, Jordan J, Yousefi K, Lam LLC, Kolisnik T, Chelissery J, Seiler R, Ross AE, Karnes RJ, Schaeffer EM, Lotan TT, Den RB, Freedland SJ, Davicioni E, Klein EA, Schalken JA.

Oncotarget. 2017 Feb 7;8(31):50804-50813. doi: 10.18632/oncotarget.15133. eCollection 2017 Aug 1.

38.

Re: Formalin Disinfection of Prostate Biopsy Needles May Reduce Post-Biopsy Infectious Complications.

Schaeffer EM.

J Urol. 2017 Sep;198(3):464. doi: 10.1016/j.juro.2017.06.006. Epub 2017 Jun 9. No abstract available.

PMID:
28817880
39.

AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.

Haffner MC, Esopi DM, Chaux A, Gürel M, Ghosh S, Vaghasia AM, Tsai H, Kim K, Castagna N, Lam H, Hicks J, Wyhs N, Biswal Shinohara D, Hurley PJ, Simons BW, Schaeffer EM, Lotan TL, Isaacs WB, Netto GJ, De Marzo AM, Nelson WG, An SS, Yegnasubramanian S.

Nat Commun. 2017 Jul 26;8(1):142. doi: 10.1038/s41467-017-00084-8.

40.

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.

Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME.

J Urol. 2018 Jan;199(1):126-132. doi: 10.1016/j.juro.2017.07.070. Epub 2017 Jul 20.

41.

Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen Receptor.

Tilki D, Schaeffer EM, Evans CP.

Eur Urol Focus. 2016 Dec;2(5):499-505. doi: 10.1016/j.euf.2016.11.013. Epub 2016 Dec 9. Review.

PMID:
28723515
42.

Contemporary management of men with high-risk localized prostate cancer in the United States.

Weiner AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener SE.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):283-288. doi: 10.1038/pcan.2017.5. Epub 2017 Jun 20. Erratum in: Prostate Cancer Prostatic Dis. 2017 Dec;20(4):442.

PMID:
28631720
43.
44.

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.

Urbanucci A, Barfeld SJ, Kytölä V, Itkonen HM, Coleman IM, Vodák D, Sjöblom L, Sheng X, Tolonen T, Minner S, Burdelski C, Kivinummi KK, Kohvakka A, Kregel S, Takhar M, Alshalalfa M, Davicioni E, Erho N, Lloyd P, Karnes RJ, Ross AE, Schaeffer EM, Vander Griend DJ, Knapp S, Corey E, Feng FY, Nelson PS, Saatcioglu F, Knudsen KE, Tammela TLJ, Sauter G, Schlomm T, Nykter M, Visakorpi T, Mills IG.

Cell Rep. 2017 Jun 6;19(10):2045-2059. doi: 10.1016/j.celrep.2017.05.049.

45.

Re: Policies for Replacing Long-Term Indwelling Urinary Catheters in Adults.

Schaeffer EM.

J Urol. 2017 Jun;197(6):1462. doi: 10.1016/j.juro.2017.03.021. Epub 2017 Mar 11. No abstract available.

PMID:
28505908
46.

Re: Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on its Extra-Intestinal Virulence Status.

Schaeffer EM.

J Urol. 2017 Jun;197(6):1461-1462. doi: 10.1016/j.juro.2017.03.020. Epub 2017 Mar 11. No abstract available.

PMID:
28505907
47.

Re: Incidence and Management of Uncomplicated Recurrent Urinary Tract Infections in a National Sample of Women in the United States.

Schaeffer EM.

J Urol. 2017 Jun;197(6):1461-1462. doi: 10.1016/j.juro.2017.03.019. Epub 2017 Mar 11. No abstract available.

PMID:
28505906
48.

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.

Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll PR, Karnes RJ, Spratt DE, Feng FY.

JAMA Oncol. 2017 Dec 1;3(12):1663-1672. doi: 10.1001/jamaoncol.2017.0751.

49.

TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis.

Malek R, Gajula RP, Williams RD, Nghiem B, Simons BW, Nugent K, Wang H, Taparra K, Lemtiri-Chlieh G, Yoon AR, True L, An SS, DeWeese TL, Ross AE, Schaeffer EM, Pienta KJ, Hurley PJ, Morrissey C, Tran PT.

Cancer Res. 2017 Jun 15;77(12):3181-3193. doi: 10.1158/0008-5472.CAN-16-2797. Epub 2017 May 8.

50.

Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer.

Guedes LB, Almutairi F, Haffner MC, Rajoria G, Liu Z, Klimek S, Zoino R, Yousefi K, Sharma R, De Marzo AM, Netto GJ, Isaacs WB, Ross AE, Schaeffer EM, Lotan TL.

Clin Cancer Res. 2017 Aug 15;23(16):4693-4703. doi: 10.1158/1078-0432.CCR-17-0257. Epub 2017 Apr 26.

PMID:
28446506

Supplemental Content

Loading ...
Support Center